HEADER TRANSCRIPTION 08-AUG-06 2J14
TITLE 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS: PART2
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 165-441;
COMPND 5 SYNONYM: PPAR-DELTA, PPAR-BETA, NUCLEAR HORMONE RECEPTOR 1, NUC1,
COMPND 6 NUCI, PPARDELTA;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, PPAR,
KEYWDS 2 ZINC, RECEPTOR, ACTIVATOR, FATTY ACIDS, NUCLEAR PROTEIN, ALTERNATIVE
KEYWDS 3 SPLICING, ZINC-FINGER, DNA-BINDING, METAL-BINDING
EXPDTA X-RAY DIFFRACTION
AUTHOR R.EPPLE,M.AZIMIOARA,R.RUSSO,Y.XIE,X.WANG,C.COW,J.WITYAK,D.KARANEWSKY,
AUTHOR 2 B.BURSULAYA,A.KREUSCH,T.TUNTLAND,A.GERKEN,M.ISKANDAR,E.SAEZ,
AUTHOR 3 H.M.SEIDEL,S.S.TIAN
REVDAT 4 13-DEC-23 2J14 1 REMARK
REVDAT 3 24-FEB-09 2J14 1 VERSN
REVDAT 2 27-SEP-06 2J14 1 JRNL
REVDAT 1 06-SEP-06 2J14 0
JRNL AUTH R.EPPLE,M.AZIMIOARA,R.RUSSO,Y.XIE,X.WANG,C.COW,J.WITYAK,
JRNL AUTH 2 D.KARANEWSKY,B.BURSULAYA,A.KREUSCH,T.TUNTLAND,A.GERKEN,
JRNL AUTH 3 M.ISKANDAR,E.SAEZ,H.M.SEIDEL,S.S.TIAN
JRNL TITL 3,4,5-TRISUBSTITUTED ISOXAZOLES AS NOVEL PPARDELTA AGONISTS.
JRNL TITL 2 PART 2
JRNL REF BIOORG.MED.CHEM.LETT. V. 16 5488 2006
JRNL REFN ISSN 0960-894X
JRNL PMID 16931011
JRNL DOI 10.1016/J.BMCL.2006.08.052
REMARK 2
REMARK 2 RESOLUTION. 2.80 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.0
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.70
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 899104.040
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6
REMARK 3 NUMBER OF REFLECTIONS : 16148
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.224
REMARK 3 FREE R VALUE : 0.284
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 801
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.20
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2498
REMARK 3 BIN R VALUE (WORKING SET) : 0.3510
REMARK 3 BIN FREE R VALUE : 0.4200
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4074
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 70
REMARK 3 SOLVENT ATOMS : 129
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 44.90
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.90
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -4.82000
REMARK 3 B22 (A**2) : -10.90000
REMARK 3 B33 (A**2) : 15.72000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35
REMARK 3 ESD FROM SIGMAA (A) : 0.55
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.46
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.66
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.005
REMARK 3 BOND ANGLES (DEGREES) : 1.100
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.720
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.180 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.040 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.800 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.880 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.38
REMARK 3 BSOL : 34.94
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM
REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 4 : NVP_LCI765.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP
REMARK 3 TOPOLOGY FILE 3 : WATER.TOP
REMARK 3 TOPOLOGY FILE 4 : NVP_LCI765.TOP
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: IN CHAIN A RESIDUE 207 HAS BEEN
REMARK 3 MODELLED AS ALA, NOT AS HIS DUE TO INSUFFICIENT DENSITY.
REMARK 4
REMARK 4 2J14 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-AUG-06.
REMARK 100 THE DEPOSITION ID IS D_1290029613.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NULL
REMARK 200 TEMPERATURE (KELVIN) : 110.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : NULL
REMARK 200 DETECTOR MANUFACTURER : NULL
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16248
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800
REMARK 200 RESOLUTION RANGE LOW (A) : 46.700
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6
REMARK 200 DATA REDUNDANCY : 3.100
REMARK 200 R MERGE (I) : 0.15000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90
REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.62000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: PDB ENTRY 2GWX
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.61
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.69500
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 157
REMARK 465 GLY A 158
REMARK 465 HIS A 159
REMARK 465 HIS A 160
REMARK 465 HIS A 161
REMARK 465 HIS A 162
REMARK 465 HIS A 163
REMARK 465 HIS A 164
REMARK 465 GLY A 165
REMARK 465 SER A 166
REMARK 465 GLN A 167
REMARK 465 TYR A 168
REMARK 465 ASN A 169
REMARK 465 PRO A 170
REMARK 465 GLN A 171
REMARK 465 VAL A 172
REMARK 465 ALA A 173
REMARK 465 GLY A 203
REMARK 465 LYS A 204
REMARK 465 ALA A 205
REMARK 465 GLY A 225
REMARK 465 LEU A 226
REMARK 465 VAL A 227
REMARK 465 TRP A 228
REMARK 465 LYS A 229
REMARK 465 GLN A 230
REMARK 465 LEU A 231
REMARK 465 VAL A 232
REMARK 465 ASN A 233
REMARK 465 GLY A 234
REMARK 465 TYR A 441
REMARK 465 MET B 157
REMARK 465 GLY B 158
REMARK 465 HIS B 159
REMARK 465 HIS B 160
REMARK 465 HIS B 161
REMARK 465 HIS B 162
REMARK 465 HIS B 163
REMARK 465 HIS B 164
REMARK 465 GLY B 165
REMARK 465 SER B 166
REMARK 465 GLN B 167
REMARK 465 TYR B 168
REMARK 465 ASN B 169
REMARK 465 PRO B 170
REMARK 465 GLN B 171
REMARK 465 VAL B 172
REMARK 465 ALA B 173
REMARK 465 ASP B 174
REMARK 465 ALA B 205
REMARK 465 SER B 206
REMARK 465 HIS B 207
REMARK 465 THR B 208
REMARK 465 ALA B 209
REMARK 465 VAL B 227
REMARK 465 TRP B 228
REMARK 465 LYS B 229
REMARK 465 GLN B 230
REMARK 465 LEU B 231
REMARK 465 VAL B 232
REMARK 465 ASN B 233
REMARK 465 GLY B 234
REMARK 465 MET B 440
REMARK 465 TYR B 441
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 HIS A 207 CG ND1 CD2 CE1 NE2
REMARK 470 MET A 440 CA C O CB CG SD CE
REMARK 470 ASP B 439 CA C O CB CG OD1 OD2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 201 5.69 -63.09
REMARK 500 HIS A 207 -72.05 168.24
REMARK 500 ASP A 215 165.82 176.79
REMARK 500 PRO A 268 -72.60 -35.98
REMARK 500 LYS A 300 -46.34 -20.01
REMARK 500 ALA A 306 61.36 39.86
REMARK 500 GLU A 424 57.47 -103.02
REMARK 500 HIS A 430 130.49 -38.59
REMARK 500 ASP A 439 -81.18 -179.33
REMARK 500 SER B 199 -72.23 -49.39
REMARK 500 THR B 202 69.19 -113.65
REMARK 500 ASP B 215 174.04 179.64
REMARK 500 PRO B 268 -97.54 -33.86
REMARK 500 SER B 296 0.20 -67.88
REMARK 500 LYS B 300 -3.34 -56.24
REMARK 500 MET B 365 -71.84 -77.12
REMARK 500 ALA B 392 58.32 -108.27
REMARK 500 TYR B 394 -4.15 75.56
REMARK 500 TYR B 437 40.41 -76.55
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNI A1440
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GNI B1439
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1GWX RELATED DB: PDB
REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-
REMARK 900 ACTIVATED RECEPTORS
REMARK 900 RELATED ID: 1Y0S RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF PPAR DELTA COMPLEXED WITH GW2331
REMARK 900 RELATED ID: 2AWH RELATED DB: PDB
REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1
REMARK 900 RELATED ID: 2B50 RELATED DB: PDB
REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 2
REMARK 900 RELATED ID: 2BAW RELATED DB: PDB
REMARK 900 HUMAN NUCLEAR RECEPTOR-LIGAND COMPLEX 1
REMARK 900 RELATED ID: 2GWX RELATED DB: PDB
REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-
REMARK 900 ACTIVATED RECEPTORS
REMARK 900 RELATED ID: 3GWX RELATED DB: PDB
REMARK 900 MOLECULAR RECOGNITION OF FATTY ACIDS BY PEROXISOME PROLIFERATOR-
REMARK 900 ACTIVATED RECEPTORS
DBREF 2J14 A 157 164 PDB 2J14 2J14 157 164
DBREF 2J14 A 165 441 UNP Q03181 PPARB_HUMAN 165 441
DBREF 2J14 B 157 164 PDB 2J14 2J14 157 164
DBREF 2J14 B 165 441 UNP Q03181 PPARB_HUMAN 165 441
SEQRES 1 A 285 MET GLY HIS HIS HIS HIS HIS HIS GLY SER GLN TYR ASN
SEQRES 2 A 285 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE
SEQRES 3 A 285 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS
SEQRES 4 A 285 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR
SEQRES 5 A 285 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN
SEQRES 6 A 285 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY
SEQRES 7 A 285 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR
SEQRES 8 A 285 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU
SEQRES 9 A 285 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU
SEQRES 10 A 285 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL
SEQRES 11 A 285 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN
SEQRES 12 A 285 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL
SEQRES 13 A 285 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER
SEQRES 14 A 285 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE
SEQRES 15 A 285 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE
SEQRES 16 A 285 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU
SEQRES 17 A 285 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE
SEQRES 18 A 285 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO
SEQRES 19 A 285 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET
SEQRES 20 A 285 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET
SEQRES 21 A 285 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU
SEQRES 22 A 285 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR
SEQRES 1 B 285 MET GLY HIS HIS HIS HIS HIS HIS GLY SER GLN TYR ASN
SEQRES 2 B 285 PRO GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE
SEQRES 3 B 285 TYR ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS
SEQRES 4 B 285 LYS ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR
SEQRES 5 B 285 ALA PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN
SEQRES 6 B 285 ALA GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY
SEQRES 7 B 285 LEU PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR
SEQRES 8 B 285 ARG CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU
SEQRES 9 B 285 THR GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU
SEQRES 10 B 285 PHE LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL
SEQRES 11 B 285 HIS GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN
SEQRES 12 B 285 LYS ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL
SEQRES 13 B 285 THR ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER
SEQRES 14 B 285 ASP ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE
SEQRES 15 B 285 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE
SEQRES 16 B 285 ILE ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU
SEQRES 17 B 285 MET ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE
SEQRES 18 B 285 LEU ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO
SEQRES 19 B 285 ASP ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET
SEQRES 20 B 285 ALA ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET
SEQRES 21 B 285 MET GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU
SEQRES 22 B 285 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR
HET GNI A1440 35
HET GNI B1439 35
HETNAM GNI (3-{4-[2-(2,4-DICHLORO-PHENOXY)-ETHYLCARBAMOYL]-5-
HETNAM 2 GNI PHENYL-ISOXAZOL-3-YL}-PHENYL)-ACETIC ACID
FORMUL 3 GNI 2(C26 H20 CL2 N2 O5)
FORMUL 5 HOH *129(H2 O)
HELIX 1 1 ASP A 174 PHE A 190 1 17
HELIX 2 2 THR A 193 LEU A 201 1 9
HELIX 3 3 ASP A 215 LYS A 224 1 10
HELIX 4 4 GLU A 240 ILE A 267 1 28
HELIX 5 5 ILE A 267 LEU A 273 1 7
HELIX 6 6 PHE A 274 ILE A 297 1 24
HELIX 7 7 ALA A 306 GLY A 308 5 3
HELIX 8 8 ARG A 314 SER A 319 1 6
HELIX 9 9 ARG A 321 ALA A 340 1 20
HELIX 10 10 ASP A 344 LEU A 357 1 14
HELIX 11 11 ASN A 366 HIS A 389 1 24
HELIX 12 12 TYR A 394 GLU A 424 1 31
HELIX 13 13 HIS A 430 TYR A 437 1 8
HELIX 14 14 LEU B 175 PHE B 190 1 16
HELIX 15 15 THR B 193 THR B 202 1 10
HELIX 16 16 ASP B 215 LEU B 226 1 12
HELIX 17 17 GLU B 240 SER B 266 1 27
HELIX 18 18 SER B 269 LEU B 273 5 5
HELIX 19 19 PHE B 274 SER B 296 1 23
HELIX 20 20 ALA B 306 GLY B 308 5 3
HELIX 21 21 ARG B 314 LEU B 320 1 7
HELIX 22 22 ARG B 321 ALA B 340 1 20
HELIX 23 23 ASP B 344 LEU B 357 1 14
HELIX 24 24 ASN B 366 HIS B 389 1 24
HELIX 25 25 TYR B 394 GLU B 424 1 31
HELIX 26 26 HIS B 430 TYR B 437 1 8
SHEET 1 AA 4 PHE A 211 ILE A 213 0
SHEET 2 AA 4 GLY A 310 THR A 313 1 O PHE A 311 N ILE A 213
SHEET 3 AA 4 GLY A 302 VAL A 305 -1 O LEU A 303 N VAL A 312
SHEET 4 AA 4 VAL A 298 ASN A 299 -1 O ASN A 299 N GLY A 302
SHEET 1 BA 4 PHE B 211 ILE B 213 0
SHEET 2 BA 4 GLY B 310 THR B 313 1 O PHE B 311 N ILE B 213
SHEET 3 BA 4 GLY B 302 VAL B 305 -1 O LEU B 303 N VAL B 312
SHEET 4 BA 4 VAL B 298 ASN B 299 -1 O ASN B 299 N GLY B 302
SITE 1 AC1 18 LEU A 219 VAL A 245 PHE A 246 ARG A 248
SITE 2 AC1 18 CYS A 249 THR A 252 THR A 253 HIS A 287
SITE 3 AC1 18 LEU A 294 VAL A 298 LEU A 303 LEU A 317
SITE 4 AC1 18 ILE A 327 ILE A 328 LYS A 331 HIS A 413
SITE 5 AC1 18 MET A 417 TYR A 437
SITE 1 AC2 19 LEU B 219 VAL B 245 PHE B 246 ARG B 248
SITE 2 AC2 19 CYS B 249 THR B 252 THR B 253 HIS B 287
SITE 3 AC2 19 LEU B 294 VAL B 298 VAL B 305 VAL B 312
SITE 4 AC2 19 LEU B 317 ILE B 327 ILE B 328 LYS B 331
SITE 5 AC2 19 HIS B 413 MET B 417 TYR B 437
CRYST1 39.376 93.390 92.258 90.00 90.00 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025396 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010708 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010839 0.00000